|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,959.50 GBX | -1.01% |
|
+1.53% | +7.40% |
| Jul. 09 | Gsk plc Announces Appointment of Roy Jakobs to Non-Executive Director, Effective July 13, 2026 | CI |
| Jul. 09 | Wall Street Ignores the Sirens |  |
| Market Cap | 78.08B 105B 91.55B 84.45B 148B 9,978B 151B 1,012B 395B 4,915B 393B 384B 16,998B | P/E 2026 * |
12.5x | P/E 2027 * | 11.4x |
|---|---|---|---|---|---|
| Enterprise Value | 93.37B 125B 109B 101B 177B 11,932B 180B 1,210B 472B 5,877B 469B 460B 20,328B | EV / Sales 2026 * |
2.76x | EV / Sales 2027 * | 2.54x |
| Free-Float |
92.29% | Yield 2026 * |
3.56% | Yield 2027 * | 3.74% |
Last Transcript: GSK plc
| Jul. 09 | GSK : Deutsche Bank remains Neutral | ZD |
| Jul. 09 | Computacenter gets two price target hikes | AN |
| Jul. 06 | HSBC Upgrades GSK to Hold Rating, Boosts PT | MT |
| Jul. 06 | HSBC raises GSK; RBC cuts Close Brothers | AN |
| Jun. 30 | UBS, RBC and Citi cut easyJet; UBS lowers Mondi | AN |
| 1 day | -1.01% | ||
| 1 week | +1.53% | ||
| Current month | -1.09% | ||
| 1 month | +2.43% | ||
| 3 months | -7.79% | ||
| 6 months | +3.62% | ||
| Current year | +7.40% |
| 1 week | 1,951 |  | 2,049 |
| 1 month | 1,890.5 | | 2,049 |
| Current year | 1,690 | | 2,282 |
| 1 year | 1,288.6 | | 2,282 |
| 3 years | 1,242.5 | | 2,282 |
| 5 years | 1,242.5 | | 3,408.16 |
| 10 years | 1,242.5 | | 3,408.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | - | 2025-12-31 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 2023-04-30 |
| Chief Tech/Sci/R&D Officer | - | 2021-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Miels
BRD | Director/Board Member | - | 2026-05-05 |
Hal Barron
BRD | Director/Board Member | 64 | 2017-12-31 |
Jonathan Symonds
CHM | Chairman | 68 | 2019-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| Jun. 21 | Buy | Executive/Senior Manager | 9 | 0.0000% | ||
| Jun. 07 | Buy | Executive/Senior Manager | 9 | 0.0000% | ||
| May. 21 | Buy | Executive/Senior Manager | 9 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.01% | +1.53% | +38.58% | +48.90% | 105B | |
| +0.09% | +2.12% | +56.49% | +169.19% | 1,084B | |
| -1.63% | +2.02% | +66.31% | +62.70% | 634B | |
| -1.12% | -0.46% | +31.69% | +84.44% | 447B | |
| +0.18% | +2.04% | +30.19% | +26.51% | 330B | |
| -6.22% | -3.61% | +29.15% | +32.09% | 295B | |
| -1.27% | -0.56% | +27.21% | +46.39% | 285B | |
| -0.93% | -1.19% | -28.85% | -40.38% | 218B | |
| -1.19% | +0.63% | +22.43% | +66.30% | 199B | |
| -0.72% | +7.04% | +21.41% | +81.19% | 169B | |
| Average | -1.37% | +2.52% | +29.46% | +57.73% | 376.53B | |
| Weighted average by Cap. | -1.09% | +2.48% | +39.73% | +83.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33.86B 45.41B 39.71B 36.63B 64.31B 4,328B 65.4B 439B 171B 2,132B 170B 167B 7,372B | 35.59B 47.73B 41.73B 38.49B 67.59B 4,548B 68.73B 461B 180B 2,240B 179B 175B 7,748B |
| Net income | 6.5B 8.72B 7.63B 7.04B 12.35B 831B 12.56B 84.3B 32.89B 409B 32.71B 32.03B 1,416B | 7.04B 9.44B 8.25B 7.61B 13.36B 899B 13.59B 91.2B 35.58B 443B 35.38B 34.65B 1,532B |
| Net Debt | 15.29B 20.51B 17.93B 16.54B 29.04B 1,954B 29.53B 198B 77.33B 963B 76.88B 75.29B 3,329B | 12.23B 16.4B 14.34B 13.23B 23.23B 1,563B 23.62B 159B 61.86B 770B 61.5B 60.23B 2,663B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-09 | GBX 1,959.50 | -1.01% | 5,592,972 |
| 26-07-08 | GBX 1,979.50 | -1.17% | 4,243,789 |
| 26-07-07 | GBX 2,003.00 | +1.01% | 4,183,855 |
| 26-07-06 | GBX 1,983.00 | -1.59% | 15,158,597 |
| 26-07-03 | GBX 2,015.00 | +0.55% | 2,548,759 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GSK Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
